Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine (December)
Links shared publicly online about this topic.
- 0total visits
Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine (December)
View full resource at theannals.com
Tags: Vaccination, Pneumococcal Vaccine, Vaccine, Prevnar
Most Recently Shared on November 2, 2011 at 3:45 am By:
Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine (December): OBJECTIVE:To review the immunogenicity,... http://t.co/UCOTnIgs
Medical News: New Version of Pneumococcal Vaccine Gets Okay - in Product Alert, Devices and Vaccines from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a 13-valent version of the pneumococcal conjugate vaccine Prevnar for use in pediatric patients 6 months to 5 years old.” View full resource at medpagetoday.com
Most Recently Shared on February 24, 2010 at 8:42 pm By:
New Version of Pneumococcal Vaccine Gets Okay WASHINGTON (MedPage Today) -- The FDA has approved a 13-valent version .. http://bit.ly/amhGBA
FDA Approves Pneumococcal Disease Vaccine with Broader Protection
fda.gov — “The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.” View full resource at fda.gov
Most Recently Shared on February 24, 2010 at 6:31 pm By:
Len Leshin Physician, Doctor, and Pediatrician
FDA approves new #Pneumococcal Vaccine with Broader Protection for infants, toddlers http://bit.ly/9as7JB #pediatrics #Prevnar
Advertisement
